Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup

Launched by ARMAUER HANSEN RESEARCH INSTITUTE, ETHIOPIA · Dec 20, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at whether thermotherapy (a heat treatment) is a good option for treating cutaneous leishmaniasis, which is a skin infection caused by parasites, in health centers in Ethiopia. The researchers want to find out if this treatment is practical and effective in these healthcare settings. They will compare patients treated with thermotherapy to those who receive standard care without it. Patients in this study will have their skin lesions treated using a special device that heats the affected area to help heal it, and their progress will be monitored for up to three months.

To participate in this trial, individuals need to be between the ages of 12 and 60 and have specific types of skin lesions that meet certain size and location criteria. Participants will receive treatment at a health center and will be checked regularly to see how well the thermotherapy is working. It's important to note that not everyone will qualify, especially those with certain health conditions that could interfere with the treatment. This study aims to provide valuable information about a new way to treat this condition in a community health setting.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Males and females aged ≥12 and ≤60 years old.
• * Patient has a lesion that satisfies the following criteria:
• • Lesion size \< or = 4 cm (longest diameter).
• • Not located adjacent to ear, nose, eyes, lips, or close to mucosal membranes.
• • Patient with \< or = 4 CL lesions
• • Patient able to give written informed consent.
• Exclusion Criteria:
• • Any condition that prevents the patient from following the study treatment and/or the follow-up